Jefferies Maintains Hold on Oracle (ORCL) Post Q3; PT to $37
Get Alerts ORCL Hot Sheet
Price: $175.07 -5%
Rating Summary:
49 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
49 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Jefferies analyst Ross MacMillan bumped current quarter estimates and his price target on Oracle (NASDAQ: ORCL) from $36 to $37, although their is no change to the firm's overall view and its Hold rating was maintained.
MacMillan comments, "ORCL's F3Q14 results were largely in line with expectations, with some puts ($0.02 currency devaluation impact) and takes (continued strong HW, lower than expected tax rate). While Cloud bookings improvement is positive, we still don't see anything in results/guidance that argues strongly for a change in our view at this point."
Q4 EPS goes from $0.93 to $0.94.
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $31.25 yesterday.
MacMillan comments, "ORCL's F3Q14 results were largely in line with expectations, with some puts ($0.02 currency devaluation impact) and takes (continued strong HW, lower than expected tax rate). While Cloud bookings improvement is positive, we still don't see anything in results/guidance that argues strongly for a change in our view at this point."
Q4 EPS goes from $0.93 to $0.94.
For an analyst ratings summary and ratings history on Oracle click here. For more ratings news on Oracle click here.
Shares of Oracle closed at $31.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Qualcomm (QCOM) PT Raised to $195 at BofA Securities
- UnitedHealth Group (UNH) PT Lowered to $197 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share